Tweet
Zhonghua Liu Xing Bing Xue Za Zhi. 2010 Dec;31(12):1374-1378.
[Quantitative evaluation on the effectiveness of prevention and control measures against pandemic influenza A (H1N1) in Beijing, 2009.]
[Article in Chinese]
Wang XL, Yang P, Cao ZD, Zeng DJ, Wu J, Zahng Y, Qian HK, Peng XM, Liang HJ, Pang XH, Deng Y, He X, Wang QY.
Institute for Infectious Disease and Endemic Disease Control, Beijing Center for Disease Control and Prevention, Beijing 100013, China.
Abstract
OBJECTIVE: To quantitatively evaluate the effectiveness of prevention and control measures against pandemic influenza A (H1N1) in Beijing, 2009 and to provide evidence for developing and adjusting strategies for prevention and control of the disease.
METHODS: Considering the seasonality and the number of vaccination on pandemic influenza A (H1N1), data regarding pandemic influenza A (H1N1) in Beijing were collected and analyzed. Based on the dynamics of infectious disease transmission, a quantitative model for evaluation of prevention and control measures was developed.
RESULTS: Both latency and infectious periods of pandemic influenza A (H1N1) were estimated to be 1.82 days and 2.08 days, respectively. The effective reproduction numbers of the three periods were 1.13, 1.65 and 0.96, respectively. Thanks to the implementation of a series of measures to prevent and control pandemic influenza A (H1N1), the cumulative number of laboratory-confirmed cases of pandemic influenza A (H1N1) was reduced, making it much smaller than what would have been under the natural situation. Specifically, the program on pandemic (H1N1) 2009 vaccination reduced the cumulative number of laboratory-confirmed cases by 24.08% and postponed the peak time.
CONCLUSION: Measures that had been taken during this period, had greatly contributed to the successful prevention and control of pandemic influenza A (H1N1). The 2009 Pandemic (H1N1) vaccination was confirmed to have contributed to the decrease of cumulative number of laboratory-confirmed cases and postponed the peak arrival time.
PMID: 21223667 [PubMed - as supplied by publisher]
[Quantitative evaluation on the effectiveness of prevention and control measures against pandemic influenza A (H1N1) in Beijing, 2009.]
[Article in Chinese]
Wang XL, Yang P, Cao ZD, Zeng DJ, Wu J, Zahng Y, Qian HK, Peng XM, Liang HJ, Pang XH, Deng Y, He X, Wang QY.
Institute for Infectious Disease and Endemic Disease Control, Beijing Center for Disease Control and Prevention, Beijing 100013, China.
Abstract
OBJECTIVE: To quantitatively evaluate the effectiveness of prevention and control measures against pandemic influenza A (H1N1) in Beijing, 2009 and to provide evidence for developing and adjusting strategies for prevention and control of the disease.
METHODS: Considering the seasonality and the number of vaccination on pandemic influenza A (H1N1), data regarding pandemic influenza A (H1N1) in Beijing were collected and analyzed. Based on the dynamics of infectious disease transmission, a quantitative model for evaluation of prevention and control measures was developed.
RESULTS: Both latency and infectious periods of pandemic influenza A (H1N1) were estimated to be 1.82 days and 2.08 days, respectively. The effective reproduction numbers of the three periods were 1.13, 1.65 and 0.96, respectively. Thanks to the implementation of a series of measures to prevent and control pandemic influenza A (H1N1), the cumulative number of laboratory-confirmed cases of pandemic influenza A (H1N1) was reduced, making it much smaller than what would have been under the natural situation. Specifically, the program on pandemic (H1N1) 2009 vaccination reduced the cumulative number of laboratory-confirmed cases by 24.08% and postponed the peak time.
CONCLUSION: Measures that had been taken during this period, had greatly contributed to the successful prevention and control of pandemic influenza A (H1N1). The 2009 Pandemic (H1N1) vaccination was confirmed to have contributed to the decrease of cumulative number of laboratory-confirmed cases and postponed the peak arrival time.
PMID: 21223667 [PubMed - as supplied by publisher]
